Patient Right to Know Drug Prices Act Goes to President

Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when those same prescriptions would cost less out of pocket. Yet, pharmacists are often under gag orders that prevent them from telling customers about the discrepancy. If President Trump signs the Patient Right to Know Drug Prices Act now that it has been approved by both the Senate and House of Representatives, that will change. Both Minnesota Senators Amy Klobuchar and Tina Smith signed on as co-sponsors for the bill.